Answers are grounded in this paper and cite their sources.
Polyfunctionalized compounds improve motor performance and reduce oxidative stress in Parkinson’s disease models, indicating therapeutic promise.
Herein, we have identified the polyfunctionalized 1-(phenylsulfonyl)-1H-indole-2-carboxylic acid derivative MTP150 for the treatment of neurodegenerative diseases owing to its efficacy in reducing protein aggregation, modulating matrix metalloproteinase activity, mitigating neuroinflammation, and enhancing DNA damage repair pathways across in vivo Caenorhabditis elegans models of Alzheimer’s disease, Parkinson’s disease (PD), and Huntington’s disease. Further experiments in an in vivo Drosophila model of PD showed that MTP150 increased motor performance, reduced oxidative stress levels, and restored mitochondrial function in model flies. In addition, MTP150 exhibited neuroprotective effects in PD model cells, thereby supporting its therapeutic potential for this disease.
No takes yet. Share an insight, caveat, or question.
Toledano-Pinedo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: